In 2023, medical institutions across the country will use 11.4 billion tablets of metformin in the centralized procurement of selected drugs. Two well-known tertiary hospitals in China have conducted real-world clinical studies.
The efficacy and safety of the selected drug and the original drug in real clinical scenarios are consistent. The hypoglycemic effect of generic drugs is equivalent to that of original drugs. There is a 20% probability of poor efficacy in individual treatment, and patients need to take other treatments.